Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 531 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

NCT01273662

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Completed

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

NCT01545804

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

NCT02447679

Conditions: Adenocarcinoma, Adult Hepatocellular Carcinoma, Adverse Reaction to Drug, +14 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Completed

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NCT00875615

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States

View Trial Details

Completed

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

NCT00273312

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Novartis Investigative Site San Francisco, California, United States

Novartis Investigative Site Hong Kong, Shatin, NT

Novartis Investigative Site Hong Kong

Novartis Investigative Site Seoul, Korea, South Korea

View Trial Details

Completed

Added Value of Gadoxetic Acid-enhanced Liver MRI

NCT03045419

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Acceptability of Less Harmful Alternatives to Cigarettes

NCT00957424

Conditions: Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +78 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

RAD001 in Advanced Hepatocellular Carcinoma

NCT00516165

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

NCT01313377

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +17 more
Locations: CHU - Hôpital Nord Amiens, France

Centre Paul Papin Angers, France

Institut Sainte Catherine Avignon, France

Centre hospitalier de la Côte Basque Bayonne, France

View all 37 locations

View Trial Details

Completed

SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma

NCT01482442

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU Amiens #2 Amiens, France

CHU Angers #3 Angers, France

CHRU Besançon Hôpital Jean Minjoz #21 Besançon, France

Hôpital Jean Verdier #25 Bondy, France

View all 26 locations

View Trial Details